Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07215884 · ClinicalTrials.gov registry record · Phase 1

Dopamine and Sensorimotor Function in Stuttering

A Phase 1 study of Stuttering, Adult, sponsored by University of California, San Francisco.

Recruiting
Registry status
Phase 1
Development phase
40
Enrollment target
1
Study location

NCT07215884 is a Phase 1 study of Stuttering, Adult that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants, below the 661-participant average among 5 other Stuttering, Adult trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07215884, a Phase 1 study of Stuttering, Adult, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

Conditions Studied

Stuttering, Adult

Interventions

  • DRUG Placebo
  • DRUG Aripiprazole 10 MG

Study Locations (1)

California

  • Biomagentic Imaging Lab - San Francisco

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-30
Est. Completion 2026-06-30
Phase Phase 1

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07215884

The ClinicalTrials.gov registry entry for NCT07215884 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 661-participant average among 5 other Stuttering, Adult trials with a reported enrollment target (94% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stuttering, Adult appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07215884 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07215884 about?

NCT07215884 is a clinical study titled "Dopamine and Sensorimotor Function in Stuttering". This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

What is the current status of trial NCT07215884?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2025-09-30. Estimated completion is 2026-06-30.

What conditions does trial NCT07215884 study?

This clinical trial studies the following conditions: Stuttering, Adult.

What interventions are being tested in trial NCT07215884?

The interventions under investigation include: Placebo (DRUG), Aripiprazole 10 MG (DRUG).

Who is sponsoring clinical trial NCT07215884?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07215884 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stuttering, Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stuttering, Adult

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.